These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33553400)

  • 1. Compound heterozygous mutations in the neuraminidase 1 gene in type 1 sialidosis: A case report and review of literature.
    Cao LX; Liu Y; Song ZJ; Zhang BR; Long WY; Zhao GH
    World J Clin Cases; 2021 Jan; 9(3):623-631. PubMed ID: 33553400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and electrophysiological characteristics of a type 1 sialidosis patient with a novel deletion mutation in NEU1 gene.
    Fan SP; Lee NC; Lin CH
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 3):406-412. PubMed ID: 31371146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 1 Sialidosis Patient With a Novel Deletion Mutation in the NEU1 Gene: Case Report and Literature Review.
    Ahn JH; Kim AR; Lee C; Kim NKD; Kim NS; Park WY; Kim M; Youn J; Cho JW; Kim JS
    Cerebellum; 2019 Jun; 18(3):659-664. PubMed ID: 30635863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 1 sialidosis presenting with ataxia, seizures and myoclonus with no visual involvement.
    Mohammad AN; Bruno KA; Hines S; Atwal PS
    Mol Genet Metab Rep; 2018 Jun; 15():11-14. PubMed ID: 30023283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I sialidosis, a normosomatic lysosomal disease, in the differential diagnosis of late-onset ataxia and myoclonus: An overview.
    Caciotti A; Melani F; Tonin R; Cellai L; Catarzi S; Procopio E; Chilleri C; Mavridou I; Michelakakis H; Fioravanti A; d'Azzo A; Guerrini R; Morrone A
    Mol Genet Metab; 2020 Feb; 129(2):47-58. PubMed ID: 31711734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and clinical characterization of mainland Chinese patients with sialidosis type 1.
    Han X; Wu S; Wang M; Li H; Huang Y; Sui R
    Mol Genet Genomic Med; 2020 Aug; 8(8):e1316. PubMed ID: 32453490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathology of NEU1 gene in sialidosis.
    Seyrantepe V; Poupetova H; Froissart R; Zabot MT; Maire I; Pshezhetsky AV
    Hum Mutat; 2003 Nov; 22(5):343-52. PubMed ID: 14517945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Structural Characteristics of NEU1 Variants Causing Sialidosis Type 1.
    Li Y; Liu Y; Wang R; Ao R; Xiang F; Zhang X; Wang X; Yu S
    J Mov Disord; 2024 Jul; 17(3):282-293. PubMed ID: 38600684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sialidosis Type 1 with a Novel Mutation in the Neuraminidase-1 (NEU1) Gene.
    Gowda VK; Srinivasan VM; Benakappa N; Benakappa A
    Indian J Pediatr; 2017 May; 84(5):403-404. PubMed ID: 28138907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in sialidosis impair sialidase binding to the lysosomal multienzyme complex.
    Lukong KE; Landry K; Elsliger MA; Chang Y; Lefrancois S; Morales CR; Pshezhetsky AV
    J Biol Chem; 2001 May; 276(20):17286-90. PubMed ID: 11279074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A longitudinal study of Taiwanese sialidosis type 1: an insight into the concept of cherry-red spot myoclonus syndrome.
    Lai SC; Chen RS; Wu Chou YH; Chang HC; Kao LY; Huang YZ; Weng YH; Chen JK; Hwu WL; Lu CS
    Eur J Neurol; 2009 Aug; 16(8):912-9. PubMed ID: 19473359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Exome Sequencing Enables Congenital Sialidosis Type II Diagnosis in Two Siblings Presenting with Unreported Clinical Features from a Rare Homozygous Sequence Variant p.(Tyr370Cys) in
    Flores-Contreras EA; García-Ortiz JE; Robles-Espinoza CD; Zomosa-Signoret V; Becerra-Solano LE; Vidaltamayo R; Castaneda-García C; Esparza-García E; Molina-Aguilar C; Hernández-Orozco AA; Córdova-Fletes C
    Mol Syndromol; 2021 Jul; 12(4):250-257. PubMed ID: 34421504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico identification of new putative pathogenic variants in the NEU1 sialidase gene affecting enzyme function and subcellular localization.
    Bonardi D; Ravasio V; Borsani G; d'Azzo A; Bresciani R; Monti E; Giacopuzzi E
    PLoS One; 2014; 9(8):e104229. PubMed ID: 25153125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurophysiolgical implications in sialidosis type 1: a case report.
    Wang F; Lin L; Hu J; Zhang J; Wang K
    Int J Neurosci; 2022 Jun; 132(6):589-592. PubMed ID: 32988250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and serial MRI findings of a sialidosis type I patient with a novel missense mutation in the NEU1 gene.
    Sekijima Y; Nakamura K; Kishida D; Narita A; Adachi K; Ohno K; Nanba E; Ikeda S
    Intern Med; 2013; 52(1):119-24. PubMed ID: 23291686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding sialidosis spectrum by genome-wide screening: NEU1 mutations in adult-onset myoclonus.
    Canafoglia L; Robbiano A; Pareyson D; Panzica F; Nanetti L; Giovagnoli AR; Venerando A; Gellera C; Franceschetti S; Zara F
    Neurology; 2014 Jun; 82(22):2003-6. PubMed ID: 24808020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chaperone-mediated gene therapy with recombinant AAV-PPCA in a new mouse model of type I sialidosis.
    Bonten EJ; Yogalingam G; Hu H; Gomero E; van de Vlekkert D; d'Azzo A
    Biochim Biophys Acta; 2013 Oct; 1832(10):1784-92. PubMed ID: 23770387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterozygous structural variation mimicking homozygous missense mutations in NEU1 associated with presenting clinical signs in eyes alone.
    Li X; Zhang Q
    Ophthalmic Genet; 2020 Jun; 41(3):279-283. PubMed ID: 32270733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multigene panel next generation sequencing in a patient with cherry red macular spot: Identification of two novel mutations in
    Mütze U; Bürger F; Hoffmann J; Tegetmeyer H; Heichel J; Nickel P; Lemke JR; Syrbe S; Beblo S
    Mol Genet Metab Rep; 2017 Mar; 10():1-4. PubMed ID: 27942463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Pathogenic Variant in the
    Sahoo LK; Kota V; Panigrahi PK; Pattnaik S; Mishra AP; Sahoo SK;
    Neurology; 2023 Nov; 101(19):861-862. PubMed ID: 37604664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.